Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Castration Compared to Castration Plus Metformin as First Line Treatment for Patients With Advanced Prostate Cancer

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Devalingam Mahalingam, The University of Texas Health Science Center at San Antonio
ClinicalTrials.gov Identifier:
NCT01620593
First received: May 31, 2012
Last updated: September 20, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2016
  Primary Completion Date: July 2016 (Final data collection date for primary outcome measure)